<bill session="114" type="hr" number="914" updated="2017-06-02T19:35:36Z">
  <state datetime="2016-09-28">REFERRED</state>
  <status>
    <introduced datetime="2016-09-28"/>
  </status>
  <introduced datetime="2016-09-28"/>
  <titles>
    <title type="official" as="introduced">Expressing support for designation of September 2016 as "Pulmonary Fibrosis Awareness Month".</title>
    <title type="display">Expressing support for designation of September 2016 as "Pulmonary Fibrosis Awareness Month".</title>
  </titles>
  <sponsor id="412303"/>
  <cosponsors>
    <cosponsor id="412236" joined="2016-09-28"/>
  </cosponsors>
  <actions>
    <action datetime="2016-09-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-09-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="114" type="hr" number="437"/>
    <bill relation="unknown" session="114" type="sr" number="270"/>
    <bill relation="unknown" session="114" type="sr" number="596"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Commemorative events and holidays"/>
    <term name="Congressional tributes"/>
    <term name="Health personnel"/>
    <term name="Medical research"/>
    <term name="Social work, volunteer service, charitable organizations"/>
  </subjects>
  <amendments/>
  <summary date="2016-09-28T04:00:00Z" status="Introduced in House">Supports the designation of Pulmonary Fibrosis Awareness Month. (Pulmonary fibrosis is scarring of the lungs that causes breathing problems.)

Expresses continued support for more robust and accelerated research to develop more effective treatments for pulmonary fibrosis and to ultimately find a cure for the disease.

Recognizes the courage and contributions of individuals with pulmonary fibrosis who participate in clinical trials.

Commends the dedication of those working to improve the quality of life of individuals with pulmonary fibrosis and the families of those individuals.</summary>
  <committee-reports/>
</bill>
